Alector, Inc.
General ticker "ALEC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $186.0M (TTM average)
Alector, Inc. follows the US Stock Market performance with the rate: 37.5%.
Estimated limits based on current volatility of 5.4%: low 1.11$, high 1.24$
Factors to consider:
- Total employees count: 238 (-2.5%) as of 2024
- Top business risk factors: Economic downturns and volatility, Limited operating history, Clinical trial delays, Labor/talent shortage/retention, Market volatility
- Current price 21.1% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.53$, 4.03$]
- 2025-12-31 to 2026-12-31 estimated range: [1.62$, 4.00$]
Financial Metrics affecting the ALEC estimates:
- Positive: with PPE of -1.5 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: 18.93 < Shareholder equity ratio, % of 27.08 <= 41.86
- Negative: Operating cash flow per share per price, % of -130.62 <= 0.33
- Positive: Investing cash flow per share per price, % of 60.87 > -0.66
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term ALEC quotes
Long-term ALEC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $133.62MM | $97.06MM | $100.56MM |
| Operating Expenses | $271.45MM | $248.80MM | $245.56MM |
| Operating Income | $-137.83MM | $-151.74MM | $-145.00MM |
| Non-Operating Income | $7.78MM | $26.56MM | $26.08MM |
| R&D Expense | $210.42MM | $192.12MM | $185.94MM |
| Income(Loss) | $-130.06MM | $-125.18MM | $-118.92MM |
| Taxes | $3.25MM | $5.21MM | $0.13MM |
| Profit(Loss)* | $-133.31MM | $-130.39MM | $-119.05MM |
| Stockholders Equity | $214.44MM | $134.16MM | $126.80MM |
| Assets | $787.65MM | $621.83MM | $468.30MM |
| Operating Cash Flow | $-20.33MM | $-184.16MM | $-229.91MM |
| Capital expenditure | $4.12MM | $2.38MM | $1.25MM |
| Investing Cash Flow | $-159.01MM | $101.92MM | $107.13MM |
| Financing Cash Flow | $4.51MM | $2.55MM | $81.54MM |
| Earnings Per Share** | $-1.62 | $-1.56 | $-1.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.